Skip to main content

GENERAL COMMENTARY article

Front. Immunol., 03 March 2015
Sec. Inflammation

Corrigendum: Depletion of Tumor-Associated Macrophages Slows the Growth of Chemically Induced Mouse Lung Adenocarcinomas

\r\n      Jason M. FritzJason M. Fritz1Meredith A. TennisMeredith A. Tennis2David J. OrlickyDavid J. Orlicky3Hao YinHao Yin1Cynthia JuCynthia Ju1Elizabeth F. RedenteElizabeth F. Redente4Kevin S. ChooKevin S. Choo5Taylor A. StaabTaylor A. Staab5Ronald J. BouchardRonald J. Bouchard5Daniel T. MerrickDaniel T. Merrick3Alvin M. MalkinsonAlvin M. Malkinson1Lori D. Dwyer-Nield*Lori D. Dwyer-Nield1*
  • 1Department of Pharmaceutical Sciences, Skaggs School of Pharmacy and Pharmaceutical Sciences, University of Colorado Denver, Aurora, CO, USA
  • 2Pulmonary Division, School of Medicine, University of Colorado Denver, Aurora, CO, USA
  • 3Department of Pathology, School of Medicine, University of Colorado Denver, Aurora, CO, USA
  • 4Department of Pediatrics, National Jewish Health, Denver, CO, USA
  • 5Research Division, Eastern Colorado Veterans Administration Medical Center, Denver, CO, USA

A corrigendum on

Depletion of tumor-associated macrophages slows the growth of chemically induced mouse lung adenocarcinomas
by Fritz JM, Tennis MA, Orlicky DJ, Yin H, Ju C, Redente EF, et al. Front Immunol (2014) 5:587. doi: 10.3389/fimmu.2014.00587

In the original manuscript, Hao Yin’s name was misspelled. The correct name is Hao Yin. The incorrect spelling is Hao Lin.

The original article has been updated.

Conflict of Interest Statement

The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.

Keywords: inflammation, macrophages, programing, M1, M2

Citation: Fritz JM, Tennis MA, Orlicky DJ, Yin H, Ju C, Redente EF, Choo KS, Staab TA, Bouchard RJ, Merrick DT, Malkinson AM and Dwyer-Nield LD (2015) Corrigendum: Depletion of tumor-associated macrophages slows the growth of chemically induced mouse lung adenocarcinomas. Front. Immunol. 6:88. doi: 10.3389/fimmu.2015.00088

Received: 10 February 2015; Accepted: 16 February 2015;
Published online: 03 March 2015.

Edited and reviewed by: Deirdre R. Coombe, Curtin University, Australia

Copyright: © 2015 Fritz, Tennis, Orlicky, Yin, Ju, Redente, Choo, Staab, Bouchard, Merrick, Malkinson and Dwyer-Nield. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) or licensor are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.

*Correspondence: lori.nield@ucdenver.edu

Disclaimer: All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.